Silexion Therapeutics Ltd...

NASDAQ: SLXN · Real-Time Price · USD
7.39
0.03 (0.41%)
At close: Aug 15, 2025, 3:56 PM
7.24
-2.03%
After-hours: Aug 15, 2025, 07:47 PM EDT

Silexion Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-16.52M -5.11M -3.49M -755.22K
Depreciation & Amortization
25K 45K 57K n/a
Stock-Based Compensation
5.86M 130K 125K n/a
Other Working Capital
-2.19M -10K 317K -469.68K
Other Non-Cash Items
3.82M 317K -268K -182.34K
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
-1.58M 87K 239K -469.68K
Operating Cash Flow
-8.4M -4.53M -3.33M -1.41M
Capital Expenditures
-22K -12K -40K -4
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a -500K n/a
Sales Maturities Of Investments
n/a 507K 16K n/a
Other Investing Acitivies
n/a 78K n/a n/a
Investing Cash Flow
-22K 573K -524K n/a
Debt Repayment
-250K n/a n/a 150.01K
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
2.3M n/a 3K -2.55M
Financial Cash Flow
5.1M 522K 2.75M 116.4M
Net Cash Flow
-3.38M -3.66M -1.77M -12.76K
Free Cash Flow
-8.42M -4.54M -3.38M -1.41M